These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Myasthenia gravis after allogeneic bone marrow transplantation. Shimoda K; Gondo H; Harada M; Sano T; Nakamura M; Otsuka T; Okamura S; Niho Y Bone Marrow Transplant; 1994 Jul; 14(1):155-6. PubMed ID: 7951105 [TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis after allogeneic bone marrow transplantation: report of a new case and pathogenetic considerations. Grau JM; Casademont J; Monforte R; Marín P; Grañena A; Rozman C; Urbano-Márquez A Bone Marrow Transplant; 1990 Jun; 5(6):435-7. PubMed ID: 2369684 [TBL] [Abstract][Full Text] [Related]
6. [A patient of chronic graft-versus-host disease presenting simultaneously with polymyositis and myasthenia gravis]. Yanagihara C; Nakaji K; Tanaka Y; Yabe H; Nishimura Y Rinsho Shinkeigaku; 2001 Aug; 41(8):503-6. PubMed ID: 11889835 [TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease. Tse S; Saunders EF; Silverman E; Vajsar J; Becker L; Meaney B Bone Marrow Transplant; 1999 Feb; 23(4):397-9. PubMed ID: 10100585 [TBL] [Abstract][Full Text] [Related]
8. Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Mackey JR; Desai S; Larratt L; Cwik V; Nabholtz JM Bone Marrow Transplant; 1997 May; 19(9):939-42. PubMed ID: 9156270 [TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis as a rare complication of graft-versus-host disease following allogenic bone marrow transplantation. Boostani R; Taheri NS Curr J Neurol; 2021 Jul; 20(3):188-189. PubMed ID: 38011480 [No Abstract] [Full Text] [Related]
10. Myasthenia Gravis Associated With Thymoma And Aplastic Anemia: Case Report. Dežmalj Grbelja L; Vrhovac R; Ulamec M Acta Clin Croat; 2017 Dec; 56(4):817-820. PubMed ID: 29590742 [TBL] [Abstract][Full Text] [Related]
11. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT. Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001 [TBL] [Abstract][Full Text] [Related]
12. Influence of ultraviolet-B irradiation on engraftment, graft-versus-host disease and graft-versus-leukemia effect in a rat model for allogeneic bone marrow transplantation. Gowing H; Braakman E; Hagenbeek A; Lawler M; McCann SR; Pamphilon DH; Martens AC Bone Marrow Transplant; 1998 Apr; 21(8):801-7. PubMed ID: 9603404 [TBL] [Abstract][Full Text] [Related]
13. A possible role of low regulatory T cells in anti-acetylcholine receptor antibody positive myasthenia gravis after bone marrow transplantation. Fukatsu M; Murakami T; Ohkawara H; Saito S; Ikeda K; Kadowaki S; Sasaki I; Segawa M; Soeda T; Hoshi A; Takahashi H; Shichishima-Nakamura A; Ogawa K; Sugiura Y; Ohto H; Takeishi Y; Ikezoe T; Ugawa Y BMC Neurol; 2017 May; 17(1):93. PubMed ID: 28506261 [TBL] [Abstract][Full Text] [Related]
14. [Durable remission attained with plasmapheresis and intravenous immunoglobulin therapy in a patient with acute exacerbation of GVHD-related myasthenia gravis]. Nakashima J; Itonaga H; Fujioka M; Chiwata M; Sawayama Y; Yoshimura S; Iwanaga H; Taguchi J; Yoshida S; Miyazaki Y Rinsho Ketsueki; 2018; 59(5):480-484. PubMed ID: 29877233 [TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis after allogeneic bone marrow transplantation. A case report and a review of the literature. Zaja F; Barillari G; Russo D; Silvestri F; Fanin R; Baccarani M Acta Neurol Scand; 1997 Oct; 96(4):256-9. PubMed ID: 9325479 [TBL] [Abstract][Full Text] [Related]
16. Change of immunological parameters in the clinical course of a myasthenia gravis patient with chronic graft-versus-host disease. Hayashi M; Matsuda O; Ishida Y; Kida K Acta Paediatr Jpn; 1996 Apr; 38(2):151-5. PubMed ID: 8677793 [TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation. Baron F; Sadzot B; Wang F; Beguin Y Bone Marrow Transplant; 1998 Jul; 22(2):197-200. PubMed ID: 9707030 [TBL] [Abstract][Full Text] [Related]
18. [A case of successful transplantation of allogeneic bone marrow in a patient with myelocytic leukemia]. Pushkareva ST; Gordeeva AA; Selidovskin GD; Piatkin EK; Murav'eva LI Ter Arkh; 1987; 59(6):14-8. PubMed ID: 3307011 [TBL] [Abstract][Full Text] [Related]
19. Granulocyte colony-stimulating factor-primed bone marrow: an excellent stem-cell source for transplantation in acute myelocytic leukemia and chronic myelocytic leukemia. Li Y; Jiang M; Xu C; Chen J; Li B; Wang J; Hu J; Ning H; Chen H; Chen S; Hu L Chin Med J (Engl); 2015 Jan; 128(1):20-4. PubMed ID: 25563308 [TBL] [Abstract][Full Text] [Related]
20. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. Storb R; Deeg HJ; Whitehead J; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Doney K; Farewell V N Engl J Med; 1986 Mar; 314(12):729-35. PubMed ID: 3513012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]